-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: March 2011
BIO Europe Spring – State of the Biotech Industry
BIO Industry Analysis provided opening remarks at BIO Europe Spring in Milan, Italy, this morning. Dr. John Craighead shared the highlights of BIO’s latest industry update: click here for the slides in pdf format.
Patent Reform Bill good for Biotech
Patent Reform Passes the Senate and Moves to the House Posted by Roy Zwahlen, manager of intellectual property and technology transfer policy at BIO. On March 8th, the Senate approved the America Invents Act (S. 23) by an overwhelming vote of 95-5. BIO supports this bipartisan, consensus-oriented bill, formerly known as the Patent Reform Act of 2011. Once enacted into law, it will strengthen and improve our nation’s patent system, spurring innovation and job creation. Patents are often Read More >
Patently BIOtech
1 Comment
Email This Post
Tags: America Invents Act, best mode, BIO, BIOTECH, Biotechnology Industry, bipartisan, False marking, false patent marking, First inventor to file, First to file, first to invent, Grassley, Leahy, Patent and Trademark Office, Patent Reform, PTO, PTO Reexaminations, Senate Judiciary Comm, USPTO
Tags: America Invents Act, best mode, BIO, BIOTECH, Biotechnology Industry, bipartisan, False marking, false patent marking, First inventor to file, First to file, first to invent, Grassley, Leahy, Patent and Trademark Office, Patent Reform, PTO, PTO Reexaminations, Senate Judiciary Comm, USPTO
Patent Reform Passes the Senate and Moves to the House
On March 8th, the Senate approved the America Invents Act (S. 23) by an overwhelming vote of 95-5. BIO supports this bipartisan, consensus-oriented bill, formerly known as the Patent Reform Act of 2011. Once enacted into law, it will strengthen and improve our nation’s patent system, spurring innovation and job creation. Patents are often the main assets of small biotech companies, and they rely on this intellectual property to attract investors to fund the lengthy Read More >
President of the EPO says Unitary Patent Still on Track
Before answering this question, I must say that one thing has always astonished me: while Europe, or at least quite a number of EU Member States, was able to adopt a common currency after a relatively short period of negotiation considering the importance and sensitivity of the issue, it seems much more difficult to obtain a common patent with a single litigation system even though this is an absolute economic and legal necessity. First came Read More >
Uganda Sets Aside GM Ban to Save Banana Crops
Excerpted from The Guardian, March 9, 2011: A typical adult in Uganda eats at least three times his or her body weight in bananas each year, more than anywhere else on Earth. Different varieties are steamed, boiled, roasted, turned into gin and beer, or simply peeled and eaten raw, such as the tiny sukali ndizi, considered by some experts to be finest banana in the world. But in recent years a devastating bacterial disease has Read More >
